Variant position: 212 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 523 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human MSAVCWLFGRHLYDTLQYPI GLIASSWGGTPIEAWSSGRSL
Mouse MSAVCWLFGRYLYDTLQYPI GLVSSSWGGTYIEVWSSRRTL
Rat MSAVCWLFGRYLYDTLQYPI GLVSSSWGGTPIEVWSSRRAL
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
24 – 523 Sialate O-acetylesterase
Functionally defective germline variants of sialic acid acetylesterase in autoimmunity.
Surolia I.; Pirnie S.P.; Chellappa V.; Taylor K.N.; Cariappa A.; Moya J.; Liu H.; Bell D.W.; Driscoll D.R.; Diederichs S.; Haider K.; Netravali I.; Le S.; Elia R.; Dow E.; Lee A.; Freudenberg J.; De Jager P.L.; Chretien Y.; Varki A.; Macdonald M.E.; Gillis T.; Behrens T.W.; Bloch D.; Collier D.; Korzenik J.; Podolsky D.K.; Hafler D.; Murali M.; Sands B.; Stone J.H.; Gregersen P.K.; Pillai S.;
Cited for: SUBCELLULAR LOCATION; VARIANTS AIS6 PHE-196; ARG-212; TRP-230; GLY-266; PRO-309; CYS-349; HIS-393; SER-404 AND CYS-479; VARIANTS GLY-3; SER-33; HIS-62; SER-64; ARG-71; VAL-89; LYS-161; MET-312; HIS-314; ASN-400; ARG-447; ILE-456 AND ARG-462; CHARACTERIZATION OF VARIANTS AIS6 PHE-196; ARG-212; TRP-230; GLY-266; PRO-309; CYS-349; HIS-393; SER-404 AND CYS-479; CHARACTERIZATION OF VARIANTS GLY-3; SER-33; HIS-62; SER-64; VAL-89; LYS-161; MET-312; HIS-314; ASN-400; ARG-447; ILE-456 AND ARG-462;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.